Researchers call for new tactics in drug abuse fight

August 2, 2012
Issues in Science and Technology is the award-winning journal of the National Academy of Sciences, National Academy of Engineering, Institute of Medicine, and the University of Texas at Dallas.

(Medical Xpress) -- Current U.S. drug policy is proving insufficient in shrinking the damage caused by drug abuse, but promising alternative approaches could lead to improved results, according to an article in the summer 2012 edition of Issues in Science and Technology.

Although the current U.S. approach is comprehensive, involving policies ranging from arresting and imprisoning drug dealers to suspending the licenses of drunk drivers, it has failed to reduce the overall size of the problem, according to the article by Mark A.R. Kleiman of the University of California at Los Angeles and colleagues.

They argue that less comprehensive but more targeted drug enforcement might be the better course. These include testing and sanctions programs, interventions to shrink flagrant retail markets, collective directed at violent -dealing organizations, and law enforcement aimed at deterring and incapacitating unusually violent individual dealers.

Also in the summer 2012 Issues, Mark Sagoff of George Mason University argues that a new obsession with collecting huge amounts of data for scientific purposes is not an effective way to conduct research.

The data deluge, Sagoff writes, has become most suffocating in biology. make it continually faster and cheaper to produce genomic sequence data than to store, manage, and analyze them. To keep up with the flow of data, some have called for a change in the scientific method from the traditional practice that poses a hypothesis and then pursues the phenomena necessary to test it to a novel approach that uses to scan data for interesting associations.

But Sagoff argues that this results in accumulating oceans of data for no clear purpose, based on the assumption that something in the data will stimulate important questions.

According to an article by Christopher Wilson of the Woodrow Wilson Center in Washington, DC, many feared in the early 1990s that the North American Free Trade Agreement would result in business and jobs moving from the United States to Mexico. But the reality is that economic cooperation with Mexico has been a boon for U.S. industry and has strengthened the country’s competitive position in ways that have produced broad economic benefits. Today, Wilson argues that expanding economic cooperation with Mexico is one of the best ways for the United States to improve its global competitiveness.

Explore further: 'War on drugs' is fueling HIV epidemic: report

Related Stories

'War on drugs' is fueling HIV epidemic: report

June 26, 2012
A pressure group that includes six former presidents called Tuesday for the United Nations to acknowledge that "repressive drug law enforcement" was driving an HIV/AIDS pandemic.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.